Menu
Home
People
Places
Arts
History
Plants & Animals
Science
Life & Culture
Technology
Reference.org
Liver function tests
open-in-new
<p>Liver function tests (LFTs or LFs), also referred to as a hepatic panel or liver panel, are groups of blood tests that provide information about the state of a patient's <a href="/facts/Liver/Rtp4Fk2b">liver</a>. These tests include <a href="/facts/Prothrombin_time/pkLRGqcY">prothrombin time</a> (PT/INR), <a href="/facts/Activated_Partial_Thromboplastin_Time/vLzYoHoh">activated partial thromboplastin time</a> (aPTT), <a href="/facts/Albumin/gDmSgAH2">albumin</a>, <a href="/facts/Bilirubin/HCHyCjkt">bilirubin</a> (direct and indirect), and others. The liver transaminases <a href="/facts/Aspartate_transaminase/ksTwpdqx">aspartate transaminase (AST or SGOT)</a> and <a href="/facts/Alanine_transaminase/PAUfv2UK">alanine transaminase (ALT or SGPT)</a> are useful biomarkers of liver injury in a patient with some degree of intact liver function. </p><p>Most <a href="/facts/Liver_disease/NHtuS0gU">liver diseases</a> cause only mild symptoms initially, but these diseases must be detected early. Hepatic (liver) involvement in some diseases can be of crucial importance. This testing is performed on a patient's blood sample. Some tests are associated with functionality (e.g., albumin), some with cellular integrity (e.g., <a href="/facts/Transaminase/5xt6gNd3">transaminase</a>), and some with conditions linked to the biliary tract (<a href="/facts/Gamma-glutamyl_transferase/KpSuNWRc">gamma-glutamyl transferase</a> and <a href="/facts/Alkaline_phosphatase/awQHo7F1">alkaline phosphatase</a>). Because some of these tests do not measure function, it is more accurate to call these liver chemistries or liver tests rather than liver function tests. </p><p>Several biochemical tests are useful in the evaluation and management of patients with hepatic dysfunction. These tests can be used to detect the presence of liver disease. They can help distinguish among different types of liver disorders, gauge the extent of known liver damage, and monitor the response to treatment. Some or all of these measurements are also carried out (usually about twice a year for routine cases) on individuals taking certain medications, such as anticonvulsants, to ensure that these medications are not adversely impacting the person's liver. </p>